[Corrections] Correction to Lancet Oncol 2018; 19: 434–36

Curigliano G. Addition of platinum salts to neoadjuvant chemotherapy in triple-negative breast cancer: a new standard of care? Lancet Oncol 2018; 19: 434–36—In this Comment, the bracketed text in the third sentence of the first paragraph should have read, "(168 [53%] of 316 patients vs 49 [31%] of 158 patients, p<0·0001)", and the bracketed text in the fourth sentence of the second paragraph should have read, "(26 [57%] of 46 patients in the paclitaxel plus carboplatin plus veliparib group vs 12 [50%] of 24 in the paclitaxel plus carboplatin group vs nine [41%] of 22 in the paclitaxel alone group)".

https://ift.tt/2E1NPuH